Albireo Expands Team, Appoints Martha J. Carter as Chief Regulatory Officer

BOSTON, Nov. 29, 2016 -- (Healthcare Sales & Marketing Network) -- Albireo Pharma, Inc. (ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced the appointment of Martha J. (Muffy) Carter as Ch... Biopharmaceuticals, Personnel Albireo Pharma, bile acid modulators, liver disease
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news